Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis

Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission as the first and only targeted medicine for eosinophilic oesophagitis (EoE), the companies announced.

Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children

Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended for use in the EU to treat severe atopic dermatitis in children aged six months to five years who are candidates for ... this chronic disease," George Yancopoulos, Regeneron’s president

Moderna and CytomX to partner in deal worth up to 1.2bn

Moderna and CytomX to partner in deal worth up to 1.2bn In November 2022, the company announced a collaboration and licensing agreement with Regeneron to create conditionally-activated investigational bispecific cancer therapies. ... The partnership will also utilise the company’s Probody platform, along

Sanofi/ Regeneron’s Dupixent recommended by CHMP to treat eosinophilic oesophagitis

Sanofi/ Regeneron’s Dupixent recommended by CHMP to treat eosinophilic oesophagitis Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) to treat adults and adolescent patients

Sanofi and Regeneron’s Dupixent granted EC approval for prurigo nodularis

Sanofi and Regeneron’s Dupixent granted EC approval for prurigo nodularis Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission (EC) for the treatment of adult patients with moderate-to-severe prurigo nodularis who are candidates for systemic ... devastating impact on their day-to-day lives,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...